Breast Cancer Imaging: A Multidisciplinary, Multimodality Approach

Breast Cancer Imaging: A Multidisciplinary, Multimodality Approach

Volumn , Issue , 2008, Pages 1-614

  Tartar, Marie ^a,b   Comstock, Christopher E ^b   Kipper, Michael S ^b  

^a SCRIPPS GREEN HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951859925     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (497)

1. A Jemal, T Murray, E Ward, et al. (2005) Cancer statistics, 2005. CA Cancer J Clin 55 10-30.
2. LAG Ries, MP Eisner, CL Kosary, et al. (2004) SEER cancer statistics review, 1975–2001 Bethesda, MD: National Cancer Institute
3. EB Elkin, C Hudis, CB Begg and D Schrag (2005) The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975–1999. Cancer 104(6), 1149-1157.
4. DA Berry, KA Cronin, SK Plevritis, et al. (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353 1784-1792.
5. RA Smith, SW Duffy, R Gabe, et al. (2004) The random-ized trials of breast cancer screening: what have we learned? Radiol Clin North Am 42(5), 793-806. v.
6. S Shapiro, W Venet, P Strax and L Venet (1988) Periodic screening for breast cancer: the Health Insurance Plan Project and its Sequelae, 1963–1986 Baltimore: Johns Hopkins University Press
7. L Tabar, B Vitak, HH Chen, et al. (2000) The Swedish Two-County Trial twenty years later. Radiol Clin North Am 38 625-652.
8. FE Alexander, TJ Anderson, HK Brown, et al. (1999) 14 years of follow-up from Edinburgh randomized trial of breast cancer screening. Lancet 353 1903-1908.
9. I Andersson, K Aspegren, L Janzon, et al. (1988) Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 297 943-948.
10. J Frisell, E Lidbrink, L Hellstrom and LE Rutqvist (1997) Follow-up after 11 years: update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 45 263-270.
11. N Bjurstam, L Bjorneld and SW Duffy (1997) The Gothenburg Breast Screening Trial: first results on mortality, incidence, and mode of detection for women ages 39–49 years at randomization. Cancer 80 2091-2099.
12. RE Hendrick, RA Smith, JH Rutledge 3rd and CR Smart (1997) Benefit of screening mammography in women aged 40–49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 22 87-92.
13. KC Chu, CR Smart and RE Tarone (1988) Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst 80 1125-1132.
14. N Bjurstam, L Bjorneld, J Warwick, et al. (2003) The Gothenburg Breast Screening Trial. Cancer 97 2387-2396.
15. I Andersson and L Janzon (1997) Reduced breast cancer mortality in women under 50: updated results from the Malmo Mammographic Screening Program. J Natl Cancer Inst Monogr 22 63-68.
16. L Liberman, DD Dershaw, BM Deutch, et al. (1993) Screening mammography: value in women 35–39 years old. AJR Am J Roentgenol 161 53-56.
17. BN Curpen, EA Sickles, RA Sollitto, et al. (1995) The comparative value of mammographic screening for women 40–49 years old versus women 50–64 years old. AJR Am J Roentgenol 164 1099-1103.
18. EA Sickles (1989) Breast masses: mammographic evaluation. Radiology 173(2), 297-303. Review
19. EA Sickles (1990) Mammographic features of malignancy found during screening. Recent Results Cancer Res 119 88-93. Review
20. RD Rosenberg, BC Yankaskas, LA Abraham, et al. (2006) Performance benchmarks for screening mammography. Radiology 241 55-66.
21. SD Frankel, EA Sickles, BN Curpen, et al. (1995) Initial versus subsequent screening mammography: comparison of findings and their prognostic significance. AJR Am J Roentgenol 164 1107-1109.
22. U Fischer, F Baum, S Obenauer, et al. (2002) Comparative study in patients with microcalcifications: full-field digital mammography vs screen-film mammography. Eur Radiol 12 2679-2683.
23. JM Lewin, RE Hendrick, CJ D'Orsi, et al. (2001) Comparison of full-field digital mammography to screen-film mammography for cancer detection: results of 4945 paired examinations. Radiology 218 873-880.
24. ED Pisano, C Gatsonis, E Hendrick, et al. (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353 1773-1783.
25. TW Freer and MJ Ulissey (2001) Screening mammography with computer-aided detection: prospective study of 12,860 patients in a community breast center. Radiology 220(3), 781-786.
26. RL Birdwell, P Bandodkar and DM Ikeda (2005) Computer-aided detection with screening mammography in a university hospital setting. Radiology 236(2), 451-457.
27. MJ Morton, DH Whaley, KR Brandt and KK Amrami (2006) Screening mammograms: interpretation with computer-aided detection—prospective evaluation. Radiology 239(2), 375-383.
28. D Gur, JH Sumkin, HE Rockette, et al. (2004) Changes in breast cancer detection and mammography recall rates after the introduction of a computer-aided detection system. J Natl Cancer Inst 96(3), 185-190.
29. JJ Fenton, SH Taplin, PA Carney, et al. (2007) Influence of computer-aided detection on performance of screening mammography. N Engl J Med 356(14), 1399-1409.
30. M Bazzocchi, C Zuiani, P Panizza, et al. (2006) Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial. AJR Am J Roentgenol 186 1723-1732.
31. CK Kuhl, S Schrading, HB Bieling, et al. (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370(9586), 485-492.
32. M Kriege, CT Brekelmans, C Boetes, et al. (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5), 427-437.
33. CD Lehman, JD Blume, P Weatherall, et al. (2005) Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103 1898-1905.
34. CK Kuhl, S Schrading, CC Leutner, et al. (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23(33), 8469-8476.
35. D Saslow, C Boetes, W Burke, et al. (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2), 75-89.
36. C Cole-Beuglet, BB Goldberg, AB Kurtz, et al. (1982) Clinical experience with a prototype realtime dedicated breast scanner. AJR Am J Roentgenol 139 905-911.
37. EA Sickles, RA Filly and PW Callen (1983) Breast cancer detection with sonography and mammography: comparison using state-of-the-art equipment. AJR Am J Roentgenol 140 843-845.
38. RL Egan and KL Egan (1984) Automated water-path full-breast sonography: correlation with histology of 176 solid lesions. AJR Am J Roentgenol 143 499-507.
39. RL Egan, MB McSweeney and FB Murphy (1984) Breast sonography and the detection of breast cancer. Recent Results Cancer Res 90 90-100.
40. DB Kopans, JE Meyer and KK Lindfors (1985) Whole-breast US imaging: four-year follow-up. Radiology 157 505-507.
41. PB Gordon and SL Goldenberg (1995) Malignant breast masses detected only by ultrasound. Cancer 76 626-630.
42. TM Kolb, J Lichy and JH Newhouse (1998) Occult cancer in women with dense breasts: detection with screening US—diagnostic yield and tumor characteristics. Radiology 207 191-199.
43. W Buchberger, P DeKoekkoek-Doll, P Springer, et al. (1999) Incidental findings on sonography of the breast: clinical significance and diagnostic workup. AJR Am J Roentgenol 173 921-927.
44. W Buchberger, A Niehoff, A Obrist, et al. (2000) Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MR 21 325-336.
45. SS Kaplan (2001) Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology 221 641-649.
46. TM Kolb, J Lichy and JH Newhouse (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225 165-175.
47. I Leconte, C Feger, C Galant, et al. (2003) Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density. AJR Am J Roentgenol 180 1675-1679.
48. P Crystal, S Strano, S Shcharynski and MJ Koretz (2003) Using sonography to screen women with mammographically dense breasts. AJR Am J Roentgenol 181 177-182.
49. L Cortesi, D Turchetti, I Marchi, et al. (2006) Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience. BMC Cancer 6 210.
50. V Corsetti, A Ferrari, M Ghirardi, et al. (2006) Role of ultrasonography in detecting mammographically occult breast carcinoma in women with dense breasts. Radiol Med (Torino) 111(3), 440-448.
51. Quality Determinants of Mammography Guideline Panel (1994) Quality determinants of mammography. AHCPR Publication no. 95–0632 Rockville, MD: U.S. Department of Health and Human Services, Public Health Service
52. WA Berg, JD Blume, JB Cormack and EB Mendelson (2006) Operator dependence of physician-performed whole-breast US: lesion detection and characterization. Radiology 241(2), 355-365.
53. M Kriege, CT Brekelmans, C Boetes, et al. (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351 427-437.
54. EA Morris, L Liberman, DJ Ballon, et al. (2003) MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 181 619-626.
55. MJ Stoutjesdijk, C Boetes, GJ Jager, et al. (2001) Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 93 1095-1102.
56. E Warner, DB Plewes, KA Hill, et al. (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292 1317-1325.
57. E Warner, DB Plewes, RS Shumak, et al. (2001) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19(15), 3524-3531.
58. D Saslow, C Boetes, W Burke, et al. (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57 75-89.
59. MG Harish, SD Konda, H MacMahon, et al. (Oct 2007) Breast lesions incidentally detected with CT: What the General Radiologist Needs to Know. RadioGraphics 27 S37-S51.
60. H Agress and BZ Cooper (2004) detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology 230 417-422.
61. RD Rosenberg, BC Yankaskas, LA Abraham, et al. (2006) Performance benchmarks for screening mammography. Radiology 241 55-66.
62. American College of Radiology (ACR) (2003) Breast Imaging Reporting and Data System Atlas (BI-RADS® Atlas) Reston, Va: American College of Radiology
63. EA Sickles (1991) Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology 179(2), 463-468.
64. Report from the Physician Insurers Association of America (PIAA), 2005.
65. MA Dennis, SR Parker, AJ Klaus, et al. (2001) Breast biopsy avoidance: the value of normal mammograms and normal sonograms in the setting of a palpable lump. Radiology 219 186-191.
66. MS Soo, EL Rosen, JA Baker, et al. (2001) Negative predictive value of sonography with mammography in patients with palpable breast lesions. AJR Am J Roentgenol 177 1167-1170.
67. L Moy, PJ Slanetz, R Moore, et al. (2002) Specificity of mammography and US in the evaluation of a palpable abnormality: retrospective review. Radiology 225 176-181.
68. N Houssami, L Irwig, JM Simpson, et al. (2003) Sydney breast imaging accuracy study: comparative sensitivity and specificity of mammography and sonography in young women with symptoms. AJR Am J Roentgenol 180 935-940.
69. L Liberman and JB Kaplan (2001) Percutaneous core biopsy of nonpalpable breast lesions: utility and impact on cost of diagnosis. Breast Dis 13 49-57.
70. MB Mainiero, IF Gareen, CE Bird, et al. (2002) Preferential use of sonographically guided biopsy to minimize patient discomfort and procedure time in a percutaneous image-guided breast biopsy program. J Ultrasound Med 21 1221-1226.
71. E Rubin, ST Mennemeyer, RA Desmond, et al. (2001) Reducing the cost of diagnosis of breast carcinoma: impact of ultrasound and imaging-guided biopsies on a clinical breast practice. Cancer 91(2), 324-332.
72. SH Parker, WE Jobe, MA Dennis, et al. (1993) US-guided automated large-core breast biopsy. Radiology 187.
73. SH Parker, F Burbank, RJ Jackman, et al. (1994) Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 193.
74. JP Crowe Jr, A Rim, RJ Patrick, et al. (2003) Does core needle breast biopsy accurately reflect breast pathology? Surgery 134 526-528.
75. GB Meloni, S Dessole, MP Becchere, et al. (2001) Ultrasound-guided Mammotome vacuum biopsy for the diagnosis of impalpable breast lesions. Ultrasound Obstet Gynecol 18.
76. JR Simon, CL Kalbhen, RA Cooper and ME Flisak (2000) Accuracy and complication rates of US-guided vacuum-assisted core breast biopsy: initial results. Radiology 215.
77. W Buchberger, A Niehoff, P Obrist, et al. (2002) Sonographically guided core needle biopsy of the breast: technique, accuracy and indications. Radiology 42.
78. P Crystal, M Koretz, S Shcharynsky, et al. (2005) Accuracy of sonographically guided 14-gauge core-needle biopsy: results of 715 consecutive breast biopsies with at least two-year follow-up of benign lesions. J Clin Ultrasound 33.
79. DN Smith, ML Rosenfield Darling, JE Meyer, et al. (2001) The utility of ultrasonographically guided large-core needle biopsy: results from 500 consecutive breast biopsies. J Ultrasound Med 20.
80. DN Smith, R Christian and JE Meyer (1997) Large-core needle biopsy of nonpalpable breast cancers. The impact on subsequent surgical excisions. Arch Surg 132 260.
81. CS Kaufman, R Delbecq and L Jacobson (1998) Excising the reexcision: stereotactic core-needle biopsy decreases need for reexcision of breast cancer. World J Surg 22 1028.
82. L Liberman, LR LaTrenta, DD Dershaw, et al. (1997) Impact of core biopsy on the surgical management of impalpable breast cancer. AJR Am J Roentgenol 168.
83. DS Lind, R Minter, B Steinbach, et al. (1998) Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer. J Surg Res 78(1), 23-26.
84. JH Yim, P Barton, B Weber, et al. (1996) Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy. Ann Surg 223 697-700.
85. L Liberman, LA Ernberg, A Heerdt, et al. (2000) Palpable breast masses: is there a role for percutaneous imaging-guided core biopsy? AJR Am J Roentgenol 175.
86. J Lorenzen, J Welger, BW Lisboa, et al. (2002) Percutaneous core-needle biopsy of palpable breast tumors. Do we need ultrasound guidance? Rofo 174.
87. SV Hilton, GR Leopold, LK Olson and SA Willson (1986) Real-time breast sonography: application in 300 consecutive patients. AJR Am J Roentgenol 147.
88. HI Vargas, MP Vargas, KD Gonzalez, et al. (2004) Outcomes of sonography-based management of breast cysts. Am J Surg 188.
89. WA Berg, CI Campassi and OB Ioffe (2003) Cystic lesions of the breast: sonographic-pathologic correlation. Radiology 227.
90. W Buchberger, P DeKoekkoek-Doll, P Springer, et al. (1999) Incidental findings on sonography of the breast: clinical significance and diagnostic workup. AJR Am J Roentgenol 173.
91. EB Mendelson, WA Berg and CR Merritt (2001) Toward a standardized breast ultrasound lexicon, BI-RADS: ultrasound. Semin Roentgenol 36.
92. LA Venta, JP Kim, CE Pelloski and M Morrow (1999) Management of complex breast cysts. AJR Am J Roentgenol 173.
93. S Ciatto, P Cariaggi and P Bulgaresi (1987) The value of routine cytologic examination of breast cyst fluids. Acta Cytol 31.
94. WH Hindle, RD Arias, B Florentine and J Whang (2000) Lack of utility in clinical practice of cytologic examination of nonbloody cyst fluid from palpable breast cysts. Am J Obstet Gynecol 182.
95. DN Smith, CM Kaelin, CD Korbin, et al. (1997) Impalpable breast cysts: utility of cytologic examination of fluid obtained with radiologically guided aspiration. Radiology 204.
96. ED Pisano, LL Fajardo, DJ Caudry, et al. (2001) Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group V. Radiology 219.
97. WF Symmans, JF Cangiarella, S Gottlieb, et al. (2001) What is the role of cytopathologists in stereotaxic needle biopsy diagnosis of nonpalpable mammographic abnormalities? Diagn Cytopathol 24.
98. D Clarke, N Sudhakaran and CA Gateley (2001) Replace fine needle aspiration cytology with automated core biopsy in the triple assessment of breast cancer. Ann R Coll Surg Engl 83.
99. ME Nath, TM Robinson, H Tobon, et al. (1995) Automated large-core needle biopsy of surgically removed breast lesions: comparison of samples obtained with 14-, 16-, and 18-gauge needles. Radiology 197.
100. WA Berg, TL Krebs, C Campassi, et al. (1997) Evaluation of 14- and 11-gauge directional, vacuum-assisted biopsy probes and 14-gauge biopsy guns in a breast parenchymal model. Radiology 205(1), 203-208.
101. U Kettritz, K Rotter, I Schreer, et al. (2004) Stereotactic vacuum-assisted breast biopsy in 2874 patients: a multicenter study. Cancer 100.
102. LE Philpotts, RJ Hooley and CH Lee (2003) Comparison of automated versus vacuum-assisted biopsy methods for sonographically guided core biopsy of the breast. AJR Am J Roentgenol 180.
103. U Kettritz, K Rotter, I Schreer, et al. (2004) Stereotactic vacuum-assisted breast biopsy in 2874 patients: a multicenter study. Cancer 100.
104. ML Darling, DN Smith, SC Lester, et al. (2000) Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol 175.
105. RJ Jackman, F Burbank, SH Parker, et al. (1997) Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology 204.
106. RJ Jackman, KW Nowels, J Rodriguez-Soto, et al. (1999) Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology 210.
107. LE Philpotts, CH Lee, LJ Horvath, et al. (2000) Underestimation of breast cancer with 11-gauge vacuum suction biopsy. AJR Am J Roentgenol 175.
108. LE Philpotts, NA Shaheen, D Carter, et al. (1999) Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. AJR Am J Roentgenol 172.
109. L Liberman, JB Kaplan, EA Morris, et al. (2002) To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy? AJR Am J Roentgenol 179.
110. M Memarsadeghi, G Pfarl, C Riedl, et al. (2003) Value of 14-gauge ultrasound-guided large-core needle biopsy of breast lesions: own results in comparison with the literature. Rofo 175.
111. G Sauer, H Deissler, K Strunz, et al. (2005) Ultrasound-guided large-core needle biopsies of breast lesions: analysis of 962 cases to determine the number of samples for reliable tumour classification. Br J Cancer 92.
112. L Liberman, M Drotman, EA Morris, et al. (2000) Imaging-histologic discordance at percutaneous breast biopsy. Cancer 89.
113. CH Lee, LE Philpotts, LJ Horvath and I Tocino (1999) Follow-up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: frequency of mammographic change and false-negative rate. Radiology 212.
114. RJ Jackman, RL Birdwell and DM Ikeda (2002) Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision? Radiology 224(2), 548-554.
115. DJ Winchester, JR Bernstein, JM Jeske, et al. (2003) Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy. Arch Surg 138 622-623.
116. MC Lechner, RJ Jackman, RF Brem, et al. (1999) Lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous biopsy with surgical correlation: a multi-institutional study [abstract]. Radiology 213(P), 106.
117. G Arpino, DC Allred, SK Mohsin, et al. (2004) Lobular neoplasia on core-needle biopsy: clinical significance. Cancer 101.
118. MC Foster, MA Helvie, NE Gregory, et al. (2004) Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology 231.
119. JP Sloane and MM Mayers (1993) Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology 23 225-231.
120. C Frouge, H Tristant, J-M Guinebretiere, et al. (1995) Mammographic lesions suggestive of radial scars: microscopic findings in 40 cases. Radiology 195 623-625.
121. P Hassell, H Klein-Parker, A Worth and P Poon (1999) Radial sclerosing lesions of the breast: mammographic and pathologic correlation. Can Assoc Radiol J 50 370-375.
122. LE Philpotts, NA Shaheen, KS Jain, et al. (2000) Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 216 831-837.
123. SE Kirwan, ERE Denton, RM Nash, et al. (2000) Multiple 14G stereotactic core biopsies in the diagnosis of mammographically detected stellate lesions of the breast. Clin Radiol 55(10), 763-766.
124. RJ Brenner, RJ Jackman, SH Parker, et al. (2002) Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary? AJR Am J Roentgenol 179.
125. JN Cawson, F Malara, A Kavanagh, et al. (2003) Fourteen-gauge needle core biopsy of mammographically evident radial scars. Is excision necessary? Cancer 97 345-351.
126. J Leung, FR Margolin, SC Lester, et al. (2002) Benign papillary breast lesions diagnosed at large-core needle biopsy: correlation with surgical pathology and clinical outcome [abstract]. AJR Am J Roentgenol 178 59-60.
127. SN Agoff and TJ Lawton (2004) Papillary lesions of the breast with and without atypical ductal hyperplasia: can we accurately predict benign behavior from core needle biopsy? Am J Clin Pathol 122.
128. CL Mercado, D Hamele-Bena, SM Oken, et al. (2006) Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology 238(3), 801-808.
129. L Liberman, E Bonaccio, D Hamele-Bena, et al. (1996) Benign and malignant phyllodes tumors: mammographic and sonographic findings. Radiology 198.
130. JE Meyer, DN Smith, SC Lester, et al. (1998) Large-needle core biopsy: nonmalignant breast abnormalities evaluated with surgical excision or repeat core biopsy. Radiology 206.
131. MA Dennis, SR Parker, AJ Klaus, et al. (2001) Breast biopsy avoidance: the value of normal mammograms and normal sonograms in the setting of a palpable lump. Radiology 219 186-191.
132. SM Durfee, DG Selland, DN Smith, et al. (2000) Sonographic evaluation of clinically palpable breast cancers invisible on mammography. Breast J 6 247-251.
133. N Houssami, L Irwig, JM Simpson, et al. (2003) Sydney breast imaging accuracy study: comparative sensitivity and specificity of mammography and sonography in young women with symptoms. AJR Am J Roentgenol 180 935-940.
134. L Moy, PJ Slanetz, R Moore, et al. (2002) Specificity of mammography and US in the evaluation of a palpable abnormality: retrospective review. Radiology 225 176-181.
135. MS Soo, EL Rosen, JA Baker, et al. (2001) Negative predictive value of sonography with mammography in patients with palpable breast lesions. AJR Am J Roentgenol 177 1167-1170.
136. SP Weinstein, EF Conant, SO Orel, et al. (2000) Retrospective review of palpable breast lesions after negative mammography and sonography. J Womens Imaging 2 15-18.
137. AT Stavros, CL Rapp and SH Parker (2003) Breast Ultrasound 1st ed. Philadelphia, PA: Lippincott Williams & Wilkins
138. Blue Cross Blue Shield (BCBSA), Technology Evaluation Center (TEC) (April 2004) Breast MRI for detection or diagnosis of primary or recurrent breast cancer. TEC Assessment Program 19 Chicago, IL: BCBSA (1)
139. SG Orel, SP Weinstein, MD Schnall, et al. (1999) Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 212 543-549.
140. VP Jackson and RL Gilmor (1983) Male breast carcinoma and gynecomastia: comparison of mammography with sonography. Radiology 149 533-536.
141. A Langlands, N Maclean and G Kerr (1976) Carcinoma of the male breast: Report of a series of 88 cases. Clin Radiol 27 21-25.
142. JA van Dongen, IS Fentiman, JR Harris, et al. (1989) In situ breast cancer: the EORTC consensus meeting. Lancet 2 25-27.
143. SJ Schnitt, JL Connolly, A Recht, et al. (1985) Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance. Int J Radiat Oncol Biol Phys 11 1277-1284.
144. H Bartelink, JH Borger, JA van Dongen and JL Peterse (1988) The impact of tumor size and histology on local control after breast conserving treatment. Radiother Oncol 11 297-303.
145. R Holland, SH Veling, M Mravunac and JH Hendricks (1985) Histologic multifocality of Tis, T1–2 breast carcinomas: implications for clinical trials of breast conserving surgery. Cancer 56 979-990.
146. LS Wilkinson, R Given-Wilson, T Hall, et al. (2005) Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound. Clin Radiol 60 573-578.
147. DE Heron, LT Komarnicky, T Hyslop, et al. (2000) Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 88 2739-2750.
148. L Liberman, EA Morris, CM Kim, et al. (2003) MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180 333-341.
149. WT Yang, J Chang and C Metreweli (2000) Patients with breast cancer: differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes. Radiology 215 568-573.
150. I Bedrosian, R Mick, SG Orel, et al. (2003) Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 98 468-473.
151. M Morrow (2004) Magnetic resonance imaging in the preoperative evaluation of breast cancer: primum non nocere. J Am Coll Surg 198 240-241.
152. M Morrow (2004) Magnetic resonance imaging in breast cancer: one step forward, two steps back? JAMA 292 2779-2780.
153. M Morrow (2005) Magnetic resonance imaging in breast cancer: is seeing always believing? Eur J Cancer 41 1368-1369.
154. U Fischer, O Zachariae, F Baum, et al. (2004) The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14 1725-1731.
155. MC Smitt, KW Nowels, MJ Zdeblick, et al. (1995) The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 76 259-267.
156. AC Neuschatz, T DiPetrillo, H Safaii, et al. (2003) Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer 97 30-39.
157. E Obedian and BG Haffty (2000) Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am 6 28-33.
158. E Provenzano, JL Hopper, GG Giles, et al. (2004) Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study. Pathology 36 221-229.
159. MF Borg (2004) Breast-conserving therapy in young women with invasive carcinoma of the breast. Australas Radiol 48 376-382.
160. MC Smitt MD and K Horst (2007) Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer. Ann Surg Oncol 14(3), 1040-1044.
161. CD Lehman, C Gatsonis, CK Kuhl, et al. (2007) ACRIN Trial 6667 Investigators Group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356(13), 1295-1303.
162. O Schillaci and JR Buscombe (2004) Breast scintigraphy today: indications and limitations. Eur J Nucl Med Mol Imaging 31(Suppl 1), S35-S45.
163. RF Brem, JM Schoonjans, DA Kieper, et al. (2002) High-resolution scintimammography: a pilot study. J Nucl Med 43 909-915.
164. RF Brem, JA Rapelyea, G Zisman, et al. (2005) Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. Radiology 237 274-280.
165. RF Brem, M Fishman and JA Rapelyea (2007) Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study. Acad Radiol 14(8), 945-950.
166. RF Brem, I Petrovitch, JA Rapelyea, et al. (2007) Breast-specific gamma imaging with (99m) Tc-sestamibi and magnetic resonance imaging in the diagnosis of breast cancer: a comparative study. Breast J 13(5), 465-469.
167. EA Levine, RI Freimanis, ND Perrier, et al. (2003) Positron emission mammography: initial clinical results. Ann Surg Oncol 10 86-91.
168. EL Rosen, TG Turkington, MS Soo, et al. (2005) Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG pet mammography device: initial experience. Radiology 234 527-534.
169. WA Berg, IN Weinberg, D Narayanan, et al. (2006) High-resolution fluorodeoxyglucose positron emission tomography with compression (“positron emission mammography”) is highly accurate in depicting primary breast cancer. Breast J 12(4), 309-323.
170. L Tafra, Z Cheng, J Uddo, et al. (2005) Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer. Am J Surg 190(4), 628-632.
171. B Fisher, S Anderson, J Bryant, et al. (2002) Twenty year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 1233-1241.
172. R Holland, SH Veling, M Mravunac and JH Hendriks (1985) Histologic multifocality of Tis, T1–2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer 56(5), 979-990.
173. U Veronesi, N Cascinelli, L Mariani, et al. (2002) Twenty year follow-up of a randomized study comparing breast conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 1227-1232.
174. DE Wazer, RK Schmidt-Ullrich, CH Schmid, et al. (1997) The value of breast lumpectomy margin assessment as a predictor of residual tumor burden. Int J Radiat Oncol Biol Phys 38(2), 291-299.
175. AT Stavros, D Thickman, CL Rapp, et al. (1995) Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 196 123-134.
176. WA Berg, IN Weinberg, D Narayanan, et al. (2006) High-resolution fluorodeoxyglucose positron emission tomography with compression (“positron emission mammography”) is highly accurate in depicting primary breast cancer. Breast J 12(4), 309-323.
177. L Tafra (2007) Positron emission tomography (PET) and mammography (PEM) for breast cancer: importance to surgeons. Ann Surg Oncol 14 3-13.
178. L Tafra, Z Cheng, J Uddo, et al. (2005) Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer. Am J Surg 190(4), 628-632.
179. EA Morris, LH Schwartz, MB Drotman, et al. (2000) Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience. Radiology 214 67-72.
180. EA Morris, LH Schwartz, MB Drotman, et al. (2000) Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience. Radiology 214(1), 67-72.
181. U Fischer, O Zachariae, F Baum, et al. (2004) The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14(10), 1725-1731.
182. KP Dhamanaskar and D Muradall (2002) MRI directed ultrasound: a cost effective method for diagnosis and intervention in breast imaging [abstract]. Radiology 225 653.
183. LR LaTrenta, JH Menell, EA Morris, et al. (2003) Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology 227 856-861.
184. P Panizza and A De Gaspari (1997) Accuracy of post MR imaging second-look sonography in previously undetected breast lesions [abstract]. Radiology 205 489.
185. H Lerman, U Metser, D Grisaru, et al. (2004) Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med 45 266-271.
186. NJ Bundred, DAL Morgan and JM Dixon (1994) ABC of breast diseases: management of regional nodes in breast cancer. BMJ 309 1222-1225.
187. I Jatoi (2003) Internal mammary sentinel nodes in primary breast cancer. Curr Med Res Opin 19(6), 567-569.
188. LR LaTrenta, JH Menell, EA Morris, et al. (2003) Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology 227 856-861.
189. SP Povoski, JO Olsen, DC Young, et al. (2006) Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol 13(11), 1412-1421.
190. C Kaplan, R Matallana and MK Wallack (1990) The use of state-of-the-art mammography in the detection of nonpalpable breast carcinoma. Am Surg 56(1), 40-42.
191. J Veltman, C Boetes, L van Die, et al. (2006) Mammographic detection and staging of invasive lobular carcinoma. Clin Imaging 30(2), 94-98.
192. WA Berg, L Gutierrez, MS NessAiver, et al. (2004) Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233(3), 830-849.
193. GM Newstead, PB Baute and HK Toth (1992) Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis. Radiology 184(3), 623-627.
194. KN Krecke and JJ Gisvold (1993) Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol 161(5), 957-960.
195. R Holland, JH Hendriks and M Mravunac (1983) Mammographically occult breast cancer: a pathologic and radiologic study. Cancer 52(10), 1810-1819.
196. DJ Hilleren, IT Andersson, K Lindholm and FS Linnell (1991) Invasive lobular carcinoma: mammographic findings in a 10-year experience. Radiology 178(1), 149-154.
197. CP Paramagul, MA Helvie and DD Adler (1995) Invasive lobular carcinoma: sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology 195(1), 231-234.
198. M Le Gal, L Ollivier, B Asselain, et al. (1992) Mammographic features of 455 invasive lobular carcinomas. Radiology 185(3), 705-708.
199. JSY Lee, CS Grant, JH Donohue, et al. (1995) Arguments against routine contralateral mastectomy or undirected biopsy for invasive lobular breast cancer. Surgery 118 640-648.
200. C Boetes, J Veltman, L van Die, et al. (2004) The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 86(1), 31-37.
201. RM Mann, J Veltman, JO Barentsz, et al. (2008) The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast. Eur J Surg Oncol 34(2), 135-142. Epub 2007 Jun 15.
202. CK Kuhl, S Schrading, HB Bieling, et al. (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370(9586), 485-492.
203. R Dhillon, P Depree, C Metcalf and E Wylie (2006) Screen-detected mucinous breast carcinoma: potential for delayed diagnosis. Clin Radiol 61(5), 423-430.
204. SE Harms and SS Harms (2004) MRI evaluation and surgical planning. Semin Breast Dis 7 159-171.
205. JH Menell, EA Morris, DD Dershaw, et al. (2005) Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 11(6), 382-390.
206. MS Soo, ME Williford, R Walsh, et al. (1995) Papillary carcinoma of the breast: imaging findings. AJR Am J Roentgenol 164 321-326.
207. R Dhillon, P Depree, C Metcalf and E Wylie (2006) Screen-detected mucinous breast carcinoma: potential for delayed diagnosis. Clin Radiol 61(5), 423-430.
208. M Kawashima, Y Tamaki, T Nonaka, et al. (2002) MR imaging of mucinous carcinoma of the breast. AJR Am J Roentgenol 179 179-183.
209. N Subhas, PV Patel, HK Pannu, et al. (2005) Imaging of pelvic malignancies with in-line FDG PET–CT: case examples and common pitfalls of FDG PET. RadioGraphics 25 1031-1043.
210. JA Harvey (2007) Unusual breast cancers: useful clues to expanding the differential diagnosis [review]. Radiology 242(3), 683-694.
211. A Saitoh, T Amemiya and N Tsuda (1997) Metastasis of breast carcinoma to eyelid and orbit of a postmenopausal woman: good response to tamoxifen therapy. Ophthalmologica 211 362-366.
212. V Talwar, AK Vaid, DC Doval, et al. (2007) Isolated intraorbital metastasis in breast carcinoma: case report. JAPI 55.
213. KK Toller, JW Gigantelli and MJ Spalding (1998) Bilateral orbital metastases from breast carcinoma: a case of false pseudotumor. Ophthalmology 105 1897-1901.
214. I Gunhan-Bilgen, EE Ustun and A Memis (2002) Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology 223(3), 829-838.
215. C Haagensen and A Stout (1943) Carcinoma of the breast: Criteria of operability. Ann Surg 118 859-868.
216. FL Greene, DL Page, ID Fleming, et al. (2002) AJCC Cancer Staging Manual 6th ed. New York: Springer Verlag
217. A Rieber, HJ Brambs, A Gabelmann, et al. (2002) Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 12(7), 1711-1719.
218. SC Partridge, JE Gibbs, Y Lu, et al. (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179 1193-1199.
219. EL Rosen, KL Blackwell, JA Baker, et al. (2003) Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 181 1275-1282.
220. V Londero, M Bazzocchi, C Del Frate, et al. (2004) Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 14(8), 1371-1379.
221. L Martincich, F Montemurro, G De Rosa, et al. (2004) Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 83(1), 67-76.
222. E Yeh, P Slanetz, DB Kopans, et al. (2005) Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184(3), 868-877.
223. P Bassa, EE Kim, T Inoue, et al. (1996) Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer. J Nucl Med 37(6), 931-938.
224. M Schelling, N Avril, J Nahrig, et al. (2000) Positron emission tomography using [(18)F]-fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 18 1689-1695.
225. HJ Biersack and H Palmedo (2003) Locally advanced breast cancer: is PET useful for monitoring primary chemotherapy? J Nucl Med 44(11), 1815-1817.
226. EL Rosen, WB Eubank and DA Mankoff (2007) FDG PET, PET/CT, and breast cancer imaging. RadioGraphics 27 S215-S229.
227. Xing Y, Ding M, Ross M, et al. Meta-analysis of sentinel lymph node biopsy following preoperative chemotherapy in patients with operable breast cancer. ASCO Annual Meeting, 2004, New Orleans, LA abstract 561.
228. TL Huston and MP Osborne (2005) Evaluating and staging the patient with breast cancer. D Ross (Ed.) Breast Cancer 2nd ed. Philadelphia: Elsevier Churchill Livingstone 309-318.
229. H Schirrmeister (2006) Detection of bone metastases in breast cancer by positron emission tomography. PET Clin 1(1), 25-32.
230. Y Chom, K Chan, W Lam, et al. (1997) Comparison of whole body MRI and radioisotope bone scintigram for skeletal metastases detection. Chin Med J (Eng1) 110(6), 485-489.
231. GJ Cook, S Houston, R Rubens, et al. (1998) Detection of bone metastases in breast cancer by 18 FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16(10), 375-379.
232. M Ohta, Y Tokuda, Y Suzuki, et al. (2001) Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99 m Tc-MDP bone scintigraphy. Nucl Med Commun 22(8), 875-879.
233. SN Yang, JA Liang, FJ Lin, et al. (2002) Comparing whole body 18F-2 deoxyglucose positron emission tomography and technetium-99 m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer. J Cancer Res Clin Oncol 128(6), 325-328.
234. T Uematsu, S Yuen, S Yukisawa, et al. (2005) Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer. AJR Am J Roentgenol 184(4), 1266-1273.
235. S Ciatto, P Pacini, V Azzini, et al. (1988) Preoperative staging of primary breast cancer: a multicentric study. Cancer 61(5), 1038-1040.
236. J Dose, C Bleckmann, S Bachmann, et al. (2002) Comparison of fluorodeoxyglucose positron emission tomography and “conventional diagnostic procedures” for the detection of distant metastases in breast cancer patients. Nucl Med Commun 23(9), 857-864.
237. JW Reinig, AJ Dwyer, DL Miller, et al. (1987) Liver metastasis detection: comparative sensitivities of MR imaging and CT scanning. Radiology 162 43-47.
238. SC Eberhardt, PH Choi, AM Bach, et al. (2003) Utility of sonography for small hepatic lesions found on computed tomography in patients with cancer. J Ultrasound Med 22(4), 335-343.
239. I Gunhan-Bilgen, EE Ustun and A Memis (2002) Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology 223(3), 829-838.
240. AC Kushwaha, GJ Whitman, CB Stelling, et al. (2000) Primary inflammatory carcinoma of the breast: retrospective review of the mammographic findings. AJR Am J Roentgenol 174 535-538.
241. GJ Whitman, AC Kushwaha, M Christofanilli, et al. (2001) Inflammatory breast cancer: current imaging perspectives. Semin Breast Dis 4(3), 122-131.
242. N Avril and LP Adler (2006) F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging. PET Clinics: Breast Cancer 1(1), 1-13.
243. RL Wahl, BA Siegel, E Coleman, et al. (2004) Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET study group. J Clin Oncol 22 277-285.
244. Y Sugawara, KR Zasadny, PV Kison, et al. (1999) splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results. J Nucl Med 40 1456-1462.
245. M Cristofanilli, AU Buzdar and GN Hortobágyi (2003) Update on the management of inflammatory breast cancer. Oncologist 8 141-148.
246. C Boetes, RD Mus, R Holland, et al. (1995) Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197 743-747.
247. N Dash, SH Chafin, RR Johnson, et al. (1999) Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer. AJR Am J Roentgenol 173 911-917.
248. EL Rosen, KL Blackwell, JA Baker, et al. (2003) Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 181 1275-1282.
249. E Yeh, P Slanetz, DB Kopans, et al. (2005) Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184 868-877.
250. MJ van de Vijver, YD He, LJ van't Veer, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 1999-2009.
251. S Paik, S Shak, G Tang, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351 2817-2826.
252. Mamounas E, Tang G, Bryant J, et al. Association between the 21-gene recurrence score assay (RS) and risk of locoregional failure in node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20 [abstract]. Presented at the San Antonio Breast Cancer Symposium 28th Annual Meeting, December 10, 2005.
253. PB Hathaway, DA Mankoff, KR Maravilla, et al. (1998) The value of combined FDG-PET and magnetic resonance imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience. Radiology 210(3), 807-814.
254. CS Yap, MA Seltzer, C Schiepers, et al. (2001) Impact of whole-body 18-FDG PET on staging and managing patients with breast cancer; the referring physician's perspective. J Nucl Med 42(9), 1334-1337.
255. A Katz, EA Strom, TA Bucholz, et al. (2000) Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 18 2817-2827.
256. WB Eubank and DA Mankoff (2004) Current and future uses of positron emission tomography in breast cancer imaging. Semin Nucl Med 34(3), 224-240.
257. TL Huston and RM Simmons (2005) Locally recurrent breast cancer after conservation therapy. Am J Surg 189(2), 229-235.
258. MC Smitt, KW Nowels, MJ Zdeblick, et al. (1995) The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 76 259-267.
259. AC Neuschatz, T DiPetrillo, H Safaii, et al. (2003) Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer 97 30-39.
260. E Obedian and BG Haffty (2000) Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am 6 28-33.
261. E Provenzano, JL Hopper, GG Giles, et al. (2004) Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study. Pathology 36 221-229.
262. MF Borg (2004) Breast-conserving therapy in young women with invasive carcinoma of the breast. Australas Radiol 48 376-382.
263. WJ Scott, LS Gobar, JD Terry, et al. (1996) Mediastinal lymph node staging of nonsmall cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 111(3), 642-648.
264. SS Kroll, MA Schusterman, HE Tadjalli, et al. (1997) Risk of recurrence after treatment of early breast cancer with skin-sparing mastectomy. Ann Surg Oncol 4 193-197.
265. MA Helvie, JE Bailey, MA Roubidoux, et al. (2002) Mammographic screening of TRAM flap breast reconstructions for detection of nonpalpable recurrent cancer. Radiology 224 211-216.
266. B Fisher, S Anderson, J Bryant, et al. (2002) Twenty-year follow up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 1233-1241.
267. WB Eubank, DA Mankoff, J Takasugi, et al. (2001) 18 Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol 19(15), 3516-3523.
268. M Lonneux, L Borbath, M Berliere, et al. (2000) The place of whole-body PET/FDG for the diagnosis of distant recurrence of breast cancer. Clin Positron Imaging 3 45-49.
269. KF Hubner, GT Smith, JA Thie, et al. (2000) The potential of F-18-FDG/PET in breast cancer: detection of primary lesions, axillary lymph node metastases, or distant metastases. Clin Positron Imaging 3 197-205.
270. HJ Gallowitsch, E Kresnik, J Gasser, et al. (2003) F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Invest Radiol 38 250-256.
271. EM Kamel, MT Wyss, MK Fehr, et al. (2003) [18F]-fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer. J Cancer Res Clin Oncol 129(3), 147-153.
272. A Estabrook and G Giron (2005) Treatment of unusual malignant neoplasias and clinical presentations. DF Roses (Ed.) Breast Cancer 2nd ed. Philadelphia: Churchill Livingstone 705-706.
273. H Lerman, U Metser, D Grisaru, et al. (2004) Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med 45 266-271.
274. LB Travis, DA Hill, GM Dores, et al. (2003) Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290(4), 465-475.
275. MA LePage, EA Kazerooni, MA Helvie, et al. (1999) Breast reconstruction with TRAM flaps: normal and abnormal appearances at CT. RadioGraphics (19), 1593-1603.
276. AC Neuschatz, T DiPetrillo, H Safaii, et al. (2003) Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer 97 30-39.
277. E Obedian and BG Haffty (2000) Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am 6 28-33.
278. MC Smitt, KW Nowels, MJ Zdeblick, et al. (1995) The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 76 259-267.
279. N Handel and MJ Silverstein (2004) Breast cancer detection in women with implants. Semin Breast Dis 7 172-181.
280. MA Helvie, JE Bailey, MA Roubidoux, et al. (2002) Mammographic screening of TRAM flap breast reconstructions for detection of nonpalpable recurrent cancer. Radiology 224 211-216.
281. MA Helvie, JE Bailey, MA Roubidoux, et al. (2002) Mammographic screening of TRAM flap breast reconstructions for detection of nonpalpable recurrent cancer. Radiology 224 211-216.
282. RK Devon, MA Rosen, C Mies, et al. (2004) Breast reconstruction with a transverse rectus abdominis myocutaneous flap: spectrum of normal and abnormal MR imaging findings. RadioGraphics 24(5), 1287-1299.
283. MA LePage, EA Kazerooni, MA Helvie, et al. (1999) Breast reconstruction with TRAM flaps: normal and abnormal appearances at CT. RadioGraphics 19 1593-1603.
284. MS Soo, PJ Kornguth, BS Hertzberg, et al. (1998) Fat necrosis in the breast: sonographic features. Radiology 206 261-269.
285. BJ Fueger, WA Weber, A Quon, et al. (2005) Performance of 2-deoxy-2-[F-18]fluoro-D glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients. Mol Imaging Biol 7 369-376.
286. CR Isasi, R Moadel and MD Blaufox (2005) A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat 90 105-112.
287. M Tastumi, C Cohade, M Mourtzikos, et al. (2006) Initial experience with FDG-PET/CT in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging 33 254-262.
288. EA Morris, LH Schwartz, MB Drotman, et al. (2000) Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience. Radiology 214 67-72.
289. A Iglesias, M Arias, P Santiago, et al. (2007) Benign breast lesions that simulate malignancy: magnetic resonance imaging with radiologic-pathologic correlation. Curr Probl Diagn Radiol 36(2), 66-82.
290. GJ Porter, AJ Evans, AH Lee, et al. (2006) Unusual benign breast lesions [review]. Clin Radiol 61(7), 562-569.
291. JA Harvey (2007) Unusual breast cancers: useful clues to expanding the differential diagnosis. Radiology 242(3), 683-694.
292. S Pojchamarnwiputh, M Muttarak, W Na-Chiangmai, et al. (2007) Benign breast lesions mimicking carcinoma at mammography. Singapore Med J 48(10), 958-968.
293. ME Foster, N Garrahan and S Williams (1998) Fibroadenoma of the breast: a clinical and pathological study. J R Coll Surg Edinb 33 16-19.
294. D Cyrlak, PM Carpenter and NB Rawal (1999) Breast imaging case of the day: florid sclerosing adenosis. RadioGraphics 19 245-247.
295. NS Nielsen and BB Nielsen (1986) Mammographic features of sclerosing adenosis presenting as a tumour. Clin Radiol 37 371-373.
296. I Günhan-Bilgen, A Memis, EE Ustün, et al. (2002) Sclerosing adenosis: mammographic and ultrasonographic findings with clinical and histopathological correlation. Eur J Radiol 44 232-238.
297. WW Lam, WC Chu, AP Tang, et al. (2006) Role of radiologic features in the management of papillary lesions of the breast. AJR Am J Roentgenol 186(5), 1322-1327.
298. S Ciatto, D Morrone, S Catarzi, et al. (1993) Radial scars of the breast: review of 38 consecutive mammographic diagnoses. Radiology 187 757-760.
299. M Kennedy, AV Masterson, M Kerin, et al. (2003) Pathology and clinical relevance of radial scars: a review. J Clin Pathol 56(10), 721-724.
300. CM Powell, ML Cranor and PP Rosen (1995) Pseudoangiomatous stromal hyperplasia: a mammary stromal tumor with myofibroblastic differentiation. Am J Surg Pathol 19 270-277.
301. MR Polger, CM Denison, S Lester, et al. (1996) Pseudoangiomatous stromal hyperplasia: mammographic and sonographic appearances. AJR Am J Roentgenol 166 349-352.
302. MA Cohen, EA Morris, PP Rosen, et al. (1996) Pseudoangiomatous stromal hyperplasia: mammographic, sonographic, and clinical patterns. Radiology 198 117-120.
303. CL Mercado, SA Naidrich and D Hamele-Bena (2004) Pseudoangiomatous stromal hyperplasia of the breast: sonographic features with histopathologic correlation. Breast J 10 427-432.
304. ML Telli, KC Horst, AE Guardino, et al. (2007) Phyllodes tumors of the breast: natural history, diagnosis, and treatment [review]. J Natl Compr Cancer Netw 5(3), 324-330.
305. LA Venta, EL Wiley, H Gabriel, et al. (1999) Imaging features of focal breast fibrosis: mammographic-pathologic correlation of noncalcified breast lesions. AJR Am J Roentgenol 173(2), 309-316.
306. NB Goel, TE Knight, S Pandey, et al. (2005) Fibrous lesions of the breast: imaging-pathologic correlation. RadioGraphics 25(6), 1547-1559.
307. GS Schwarz, M Drotman, R Rosenblatt, et al. (2006) Fibromatosis of the breast: case report and current concepts in the management of an uncommon lesion [review]. Breast J 12(1), 66-71.
308. KN Glazebrook, MJ Morton and C Reynolds (2005) Vascular tumors of the breast: mammographic, sonographic, and MRI appearances. AJR Am J Roentgenol 184 331-338.
309. K Schelfout, WA Tjalma, ID Cooremans, et al. (2001) Observations of an idiopathic granulomatous mastitis [review]. Eur J Obstet Gynecol Reprod Biol 97(2), 260-262.
310. S Bakaris, M Yuksel, P Ciragil, et al. (2006) Granulomatous mastitis including breast tuberculosis and idiopathic lobular granulomatous mastitis. Can J Surg 49(6), 427-430.
311. M Ozturk, E Mavili, G Kahriman, et al. (2007) Granulomatous mastitis: radiological findings. Acta Radiol 48(2), 150-155.
312. JP Hogge, RE Robinson, CM Magnant, et al. (1995) The mammographic spectrum of fat necrosis. RadioGraphics 15 1347-1356.
313. MS Soo (1998) Fat necrosis in the breast: sonographic features. Radiology 206 261-296.
314. R Mihai, J Christie-Brown and J Bristol (2004) Breast metastases from colorectal carcinoma. Breast 13 155-158.
315. CL Mercado, D Hamele-Bena, SM Oken, et al. (2006) Papillary lesions of the breast at percutaneous core-needle biopsy. Radiology 238(3), 801-808.
316. V Sohn, J Keylock, Z Arthurs, et al. (2007) Breast papillomas in the era of percutaneous needle biopsy. Ann Surg Oncol 14(10), 2979-2984.
317. L Liberman, E Bonaccio, D Hamele-Bena, et al. (1996) Benign and malignant phyllodes tumors: mammographic and sonographic findings. Radiology 198 121-124.
318. ML Telli, KC Horst, AE Guardino, et al. (2007) Phyllodes tumors of the breast: natural history, diagnosis, and treatment [review]. J Natl Compr Canc Netw 5(3), 324-330.
319. S Bakaris, M Yuksel, P Ciragil, et al. (2006) Granulomatous mastitis including breast tuberculosis and idiopathic lobular granulomatous mastitis. Can J Surg 49(6), 427-430.
320. RE Coleman and RO Reubens (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55 61-66.
321. E Even-Sapir (2005) Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med 46 1356-1367.
322. K Yamashita, H Koyama and H Inaji (1995) Prognostic significance of bone metastasis from breast cancer. Clin Orthop 312 89-94.
323. GA Edelstyn, PJ Gillespie and FS Grebell (1967) The radio-logical demonstration of osseous metastases: experimental observations. Clin Radiol 18 158-162.
324. JC Wittig and JG Lamont (2005) Bone metastases from breast cancer. DF Roses (Eds) Breast Cancer Phil-adelphia: Elsevier Churchill Livingstone 666-675.
325. J Muindi, RC Coombes, S Golding, et al. (1983) The role of computed tomography in the detection of bone metastases in breast cancer patients. Br J Radiol 56 233-239.
326. T Hamaoka, JE Madewell, DA Podoloff, et al. (2004) Bone Imaging in metastatic breast cancer. J Clin Oncol 22 2942-2953.
327. C Love, AS Din, MB Tomas, et al. (2003) Radionuclide bone imaging: an illustrative review. RadioGraphics 23 341-358.
328. KA Yeh, L Fortunato, JA Ridge, et al. (1995) Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money. Ann Surg Oncol 2 319-324.
329. H Schirrmeister, CA Guhlmann, K Elsner, et al. (1999) Planar bone imaging vs 18 F-PET in patients with cancer of the prostate, thyroid and lung. J Nucl Med 40(10), 1623-1629.
330. H Schirrmeister, CA Guhlmann, J Kotzerke, et al. (1999) Early detection and accurate description of extent of metastatic bone disease in breast cancer with 18F-fluoride ion and positron emission tomography. J Clin Oncol 17(8), 2381-2389.
331. H Schirrmeister, G Glatting, J Hetzel, et al. (2001) Prospective evaluation of the clinical value of planar bone scans, SPECT and F-18 labeled NaF PET in newly diagnosed lung cancer. J Nucl Med 42(12), 1800-1804.
332. H Schirrmeister (2006) Detection of bone metastases in breast cancer by positron emission tomography. PET Clinics: Breast Cancer 1(1), 25-32.
333. H Schirrmeister, CG Diedrichs, M Rentschler, et al. (1998) Positron-emission tomography of the skeletal sys-tem using 18-F Na: the incidence, pattern of the findings and distribution of benign changes. Fortschr Rontgenstr 169(3), 310-314. (in German)
334. F Crippa, R Agresti, E Seregni, et al. (1998) Prospective evaluation of fluorine–18-FDG PET in presurgical staging of the axilla in breast cancer. J Nucl Med 39(1), 4-8.
335. DH Moon, J Maddahi, DHS Silverman, et al. (1998) Accuracy of whole body fluorinie-18 FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med 39(3), 431-435.
336. E Even-Sapir, U Mester, G Flusser, et al. (2004) Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med 45(2), 272-278.
337. GJ Cook, S Houston, R Rubens, et al. (1998) Detection of bone metastases in breast cancer by 18 FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16(10), 3375-3379.
338. AF Douglas and PR Cooper (2005) Spinal column metastases from breast cancer. DF Roses (Eds) Breast Cancer Philadelphia: Elsevier Churchill Livingstone 644-652.
339. RS Hattner, J Hartmeyer and WM Wara (1982) Characterization of radiation-induced photopenic abnormalities on bone scans. Radiology 145 161-163.
340. DF Yankelevitz, CI Henschke, PH Knapp, et al. (1991) Effect of radiation therapy on thoracic and lumbar bone marrow: evaluation with MR imaging. AJR Am J Roentgenol 157 87-92.
341. IH Shon and I Fogleman (2003) F-18 FDG positron emission tomography and benign fractures. Clin Nucl Med 28(3), 171-175.
342. H Zhuang, JW Sam, TK Chacko, et al. (2003) Rapid normalization of osseous FDG uptake following traumatic or surgical fractures. Eur J Nucl Med Mol Imaging 30(8), 1096-1103.
343. T Taoka, NA Mayr, HJ Lee, et al. (2001) Factors influencing visualization of vertebral metastases on MR imaging versus bone scintigraphy. AJR Am J Roentgenol 176 1525-1530.
344. E Even-Sapir (2005) Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med 46(8), 1356-1367.
345. Hall NC, Minerich SM. Focus: 18-F NaF for bone imaging. White paper
346. H Schirrmeister, A Guhlmann, J Kotzerke, et al. (1999) Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 17 2381-2389.
347. MG Frederick, EK Paulson and RC Nelson (1997) Helical CT for detecting focal liver lesions in patients with breast carcinoma: comparison of noncontrast phase, hepatic arterial phase, and portal venous phase. J Comput Assist Tomogr 21 229-235.
348. DH Sheafor, MG Frederick, EK Paulson, et al. (1999) Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma. AJR Am J Roentgenol 172 961-968.
349. RC Semelka (2005) Hepatic imaging. Radiol Clin North Am 43(5)
350. I-M Danet, RC Semelka, P Leonardou, et al. (2003) Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 181 809-817.
351. EC Jones, JL Chezmar, RC Nelson, et al. (1992) The frequency and significance of small hepatic lesions (< 15 mm) detected by CT. AJR Am J Roentgenol 158 535-539.
352. LH Schwartz, EJ Gandras, SM Colangelo, et al. (1999) Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210 71-74.
353. GA Krakora, FV Coakley, G Williams, et al. (2004) Small hypoattenuating hepatic lesions at contrast-enhanced CT: prognostic importance in patients with breast cancer. Radiology 233 667-673.
354. HI Khalil, SA Patterson and DM Panicek (2005) Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology 235(3), 872-878.
355. TC Noone, RC Semelka, NC Balci, et al. (1999) Common occurrence of benign liver lesions in patients with newly diagnosed breast cancer investigated by MRI for suspected liver metastases. J Magn Reson Imaging 10(2), 165-169.
356. OW Hamer, DA Aguirre, G Casola, et al. (2006) Fatty liver: imaging patterns and pitfalls. RadioGraphics 26 1637-1653.
357. SC Eberhardt, PH Choi, AM Bach, et al. (2003) Utility of sonography for small hepatic lesions found on computed tomography in patients with cancer. J Ultrasound Med 22 335-343.
358. SA Patterson, HI Khalil and DM Panicek (2006) MRI evaluation of small hepatic lesions in women with breast cancer. Am J Roentgenol 187 307-312.
359. MM Osman, C Cohade, Y Nakamoto, et al. (2003) Mislocalization of lesions with PET/CT. J Nucl Med 44 240-243.
360. ST Young, EK Paulson, K Washington, et al. (1994) CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR Am J Roentgenol 163 1385-1388.
361. V Patanaphan, OM Salazar and R Ricco (1998) Breast cancer: metastatic patterns and their prognosis. South Med J 81(9), 1109-1112.
362. JP Shaw and LR Glassman (2005) Thoracic metastases from breast cancer. Breast Cancer Philadelphia: Elsevier Churchill Livingston 661-666.
363. JE Meyer and JE Munzenrider (1981) Computed tomographic demonstration of internal mammary lymph-node metastases in patients with locally recurrent breast carcinoma. Radiology 139 661-663. (A)
364. JM Thomas, WH Redding and JP Sloane (1979) The spread of breast cancer: importance of intrathoracic lymphatic route and its relevance to treatment. Br J Cancer 40 540-547.
365. IM Feirerstein, DL Jicha, HL Pass, et al. (1992) Pulmonary metastases: MR imaging with surgical correlation—a prospective study. Radiology 181 123-129.
366. NL Müller, G Gamsu and WR Webb (1985) Pulmonary nodules: detection using magnetic resonance and computed tomography. Radiology 155 687-690.
367. DM Panicek (1992) MR imaging for pulmonary metastases? Radiology 182 10-11.
368. WR Webb and HD Sustman (1992) MR imaging of thoracic disease: clinical uses. Radiology 182 621-630.
369. Y Ohno, K Sugimura and H Hatabu (2002) MR imaging of lung cancer. Eur J Radiol 44(3), 172-181.
370. FM Vogt, CU Herborn, P Hunold, et al. (2004) HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT. AJR Am J Roentgenol 183 71-78.
371. WB Eubank, DA Mankoff, J Takasugi, et al. (2001) 18Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol 19 3516-3523.
372. JF Vansteenkiste, SG Stroobants, PR De Leyn, et al. (1998) Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16(6), 2142-2149.
373. WJ Scott, LS Gobar, JD Terry, et al. (1996) Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computer tomography and positron emission tomography. J Thorac Cardiovasc Surg 111(3), 642-648.
374. F Crippa, E Seregni, R Agresti, et al. (1998) Association between [18F]-fluorodeoxyglucose uptake and postoperative histology, hormone receptor status, thymidine labeling index and p53 in primary breast cancer: a preliminary observation. Eur J Nucl Med 25 1429-1434.
375. N Avril, M Menzel, J Dose, et al. (2001) Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med 42 9-16.
376. JE Connolly Jr, JJ Erasmus and EF Patz Jr (1999) Thoracic manifestations of breast carcinoma: metastatic disease and complications of treatment. Clin Radiol 54 487-494.
377. JI Jung, HH Kim, SH Park, et al. (2004) Thoracic manifestations of breast cancer and its therapy. RadioGraphics 24 1269-1285.
378. JJ Casey, BG Stempel, EF Scanlon, et al. (1984) The solitary pulmonary nodule in the patient with breast cancer. Surgery 96 801-805.
379. H Kreisman, N Wolkove, HS Finkelstein, et al. (1983) Breast cancer and thoracic metastases: review of 119 patients. Thorax 38 175-179.
380. WR Webb, NL Müller and NP Naidich (2001) High-Resolution CT of the Lung 3rd ed. Philadelphia: Lippincott Williams & Wilkins
381. S Asad, SL Aquino, N Piyavisetpat, et al. (2004) False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. AJR Am J Roentgenol 182(4), 983-989.
382. BH Kwek, SL Aquino and AJ Fischman (2004) Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest 125 2356-2360.
383. JG Murray, JJ Erasmus, EA Bahtiarian, et al. (1997) Talc pleurodesis simulating pleural metastases on F18 FDG PET imaging. AJR Am J Roentgenol 168 359-360.
384. M Castillo (2005) Imaging the anatomy of the brachial plexus: review and self-assessment module. AJR Am J Roentgenol 185 S196-S204.
385. PB Hathaway, DA Mankoff, KR Maravilla, et al. (1999) Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience. Radiology 210 807-814.
386. A Qayyum, AD MacVicar, AR Padhani, et al. (2000) Symptomatic brachial plexopathy following treatment for breast cancer: utility of MR imaging with surface-coil techniques. Radiology 214 837-842.
387. AA Castagno and WP Shuman (1987) MR imaging in clinically suspected brachial plexus tumor. AJR Am J Roentgenol 149 1219-1222.
388. M Castillo (2005) Imaging the anatomy of the brachial plexus: review and self-assessment module. AJR Am J Roentgenol 185 S196-S204.
389. PB Hathaway, DA Mankoff, KR Maravilla, et al. (1999) Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience. Radiology 210 807-814.
390. A Qayyum, AD MacVicar, AR Padhani, et al. (2000) Symptomatic brachial plexopathy following treatment for breast cancer: utility of MR imaging with surface-coil techniques. Radiology 214 837-842.
391. KH Wittenberg and MC Adkins (2000) MR imaging of nontraumatic brachial plexopathies: frequency and spectrum of findings. RadioGraphics 20 1023-1032.
392. M Akira, H Ishikawa and S Yamamoto (2002) Drug-induced pneumonitis: thin-section CT findings in 60 patients. Radiology 224 852-860.
393. PH Camus, P Foucher, PH Bonniaud and K Ask (2001) Drug-induced infiltrative lung disease. Eur Respir J 18 93S-100.
394. SP Padley, B Adler, DM Hansell, et al. (1992) High-resolution computed tomography of drug-induced lung disease. Clin Radiol 46(4), 232-236.
395. JE Connolly Jr, JJ Erasmus, EF Patz Jr, et al. (1999) Thoracic manifestations of breast carcinoma: metastatic disease and complications of treatment. Clin Radiol 54 487-494.
396. JM Thomas, WH Redding and JP Sloane (1979) The spread of breast cancer: importance of the intrathoracic lymphatic route and its relevance to treatment. Br J Cancer 40 540-547.
397. PL Munk, NL Muller, RR Miller, et al. (1988) Pulmonary lymphangitic carcinomatosis: CT and pathologic findings. Radiology 166 705-709.
398. NU Lin, JR Bellon and EP Winer (2004) CNS metastases in breast cancer. J Clin Oncol 22 3608-3617.
399. EL Chang and S Lo (2003) Diagnosis and management of central nervous system metastases from breast cancer. Oncologist 8 398-410.
400. EC Parker and PJ Kelly (2005) Brain metastases from breast cancer. DF Roses (Eds) Breast Cancer Philadelphia: Elsevier Churchill Livingstone 633-643.
401. JC Bendell, SM Domchek, HJ Burstein, et al. (2003) Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 97(12), 2972-2977.
402. EM Rohren, JM Provenzale, DP Barboriak, et al. (2003) Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non–central nervous system malignancy. Radiology 226 181-187.
403. DH Yock (2002) Magnetic Resonance Imaging of CNS Disease: A Teaching File St. Louis: Mosby 2-19. 101, 439
404. G Sze, E Milano, C Johnson, et al. (1990) Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 11 785.
405. PC Davis, PA Hudgins, SB Peterman, et al. (1991) Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. AJNR Am J Neuroradiol 12 293.
406. AF Douglas and PR Cooper (2005) Spinal column metastases from breast cancer. DF Roses (Eds) Breast Cancer Philadelphia: Elsevier Churchill Livingstone 644-652.
407. RA Patchell, PA Tibbs, JW Walsh, et al. (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322 494-500.
408. EM Rohren, JM Provenzale, DP Barboriak, et al. (2003) Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non–central nervous system malignancy. Radiology 226 181-187.
409. MS Brown, JH Simon, SM Stemmer, et al. (1995) MR and proton spectroscopy of white matter disease induced by high-dose chemotherapy with bone marrow transplant in advanced breast carcinoma. Am J Neuroradiol 16 2013-2020.
410. G Bonadonna, P Valagussa, R Zucali, et al. (1995) Primary chemotherapy in surgically resectable breast cancer. CA Cancer J Clin 45 227-243.
411. DA Mankoff and LK Dunnwald (2006) Changes in glucose metabolism and blood flow following chemotherapy for breast cancer. N Avril (Ed.) PET Clinics 1 Philadelphia: WB Saunders 71-81. No. 1
412. MR Machiavelli, AD Romero, JE Perez, et al. (1998) Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. Cancer J Sci Am 4(2), 125-131.
413. N Wolmark, J Wang, E Mamounas, et al. (2001) Preoperative chemotherapy in patients with operable breast cancer: nine year results from national surgical adjuvant breast and bowel project B-18. J Natl Cancer Inst Monog 30 96-102.
414. DR McCready, GN Hortobagyi, SW Kau, et al. (1989) The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg 124 21-25.
415. JR Bellon, RB Livingston, WB Eubank, et al. (2004) Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC). Am J Clin Oncol 27(4), 407-410.
416. A Rieber, HJ Brambs, A Gabelmann, et al. (2002) Breast MRI for monitoring response of primary breast cancer to neoadjuvant chemotherapy. Eur Radiol 12(7), 1711-1719.
417. L Martincich, F Montemurro, G De Rosa, et al. (2004) Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 83(1), 67-76.
418. RL Wahl, K Zasadny, MA Helvie, et al. (1993) Metastatic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 11 2101-2111.
419. P Bassa, EE Kim, T Inove, et al. (1996) Evaluation of preoperative chemotherapy using PET with {fluorine-18} fluorodeoxyglucose in breast cancer. J Nucl Med 37 931-938.
420. M Schelling, N Avril, J Nahrig, et al. (2000) Positron emission tomography using [18F]–fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 18 1689-1695.
421. HJ Biersack and H Palmedo (2003) Locally advanced breast cancer: is PET useful for monitoring primary chemotherapy? J Nucl Med 44(11), 1815-1817.
422. T Jansson, J Westlin, H Ahlstrom, et al. (1995) Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? J Clin Oncol 13 1470-1477.
423. A Gennari, S Donati, B Salvador, et al. (2002) Role of 2-[18F]–fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients. Clin Breast Cancer 1 156-161. discussion 162–163
424. J Dose Schwartz, M Bader, L Jenicke, et al. (2005) Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG-PET imaging. J Nucl Med 46(7), 1144-1150.
425. CK Hoh and C Schiepers (1999) 18-FDG imaging in breast cancer. Semin Nucl Med 29 49-56.
426. F Dehdashti, FL Flanagan, JE Mortimer, et al. (1999) Positron emission tomographic assessment of “metabolic flare” to predict response of metastatic breast cancer to antiestrogen therapy. Eur J Nucl Med 26 51-56.
427. JE Mortimer, F Dehdashti, BA Siegel, et al. (2001) Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. J Clin Oncol 19 2797-2803.
428. N Joffe (1975) Metastatic involvement of the stomach secondary to breast carcinoma. AJR Am J Roentgenol 123 512-521.
429. PV Trappen, R Serreyn, AE Elewaut, et al. (1998) Abdominal pain with anorexia in patients with breast carcinoma. Ann Oncol 9 1243-1245.
430. JM Thomas, WH Redding and JP Sloane (1979) The spread of breast cancer: importance of the intrathoracic lymphatic route and its relevance to treatment. Br J Cancer 40 540-547.
431. AA Gupta, DC Kim, GA Krinsky, et al. (2004) CT and MRI of cirrhosis and its mimics. Am J Roentgenol 183 1595-1601.
432. AB Nascimento, DG Mitchell, R Rubin, et al. (Oct 2001) Diffuse desmoplastic breast carcinoma metastases to the liver simulating cirrhosis at MR imaging: report of two cases. Radiology 221 117-121.
433. ST Young, EK Paulson, K Washington, et al. (1994) CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR Am J Roentgenol 163 1385-1388.
434. B Fisher, S Anderson, J Bryant, et al. (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16), 1233-1241.
435. U Veronesi, E Marubini, L Mariani, et al. (2001) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12 997-1003.
436. K Holli, R Saaristo, J Isalo, et al. (2001) Lumpectomy with or without postoperative radiotherapy for breast cancer with favorable prognostic features: results of a randomized study. Br J Cancer 84 164-169.
437. RM Clark, T Whalen, M Levine, et al. (1996) Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88 1659-1664.
438. NIH Office of the Director: NIH Consensus Statement. Nov 1–3, 2000; 17, (4).
439. H Bartelink, L Collette, A Fourquet, et al. (2000) Impact of a boost dose of 16 Gy on the local control and cosmesis in patients with early breast cancer: The EORTC ‘boost versus no boost' trial. Int J Radiat Oncol Biol Phys 48(3), 111. abstract 1
440. P Romestaing, Y Lehingue, D Delaunay, et al. (2001) Role of a 10-Gy boost in the conservation treatment of early breast cancer: results of randomized clinical trial in Lyon, France. Int J Radiat Oncol Biol Phys 51(3), abstract 1
441. KC Horst and DR Goffinet (2002) 10 Gy vs 16 Gy electron beam boost dose in breast conservation therapy for early breast cancer: a decision analysis. Int J Radiat Oncol Biol Phys 54(2), 307.
442. FA Vicini, MB Sharpe, LL Kestin, et al. (2002) Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 54(5), 1336-1344.
443. VM Remouchamps, FA Vicini, MB Sharpe, et al. (2003) Significant reduction in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast radiation. Int J Radiat Oncol Biol Phys 55(2), 392-406.
444. CW Hurkmans, BCJ Cho, E Damen, et al. (2002) Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol 62(2), 163-171.
445. U Veronesi, F Rilke, A Luini, et al. (1987) Distribution of axillary node metastases by level of Invasion. Cancer 59 682.
446. B Fisher, N Wolmark, M Bauer, et al. (1981) The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152 765.
447. JA Dewar, D Sarrazin, E Benhamou, et al. (1987) Management of the axilla in conservatively treated breast cancer: 592 patients treated at Institut Gustave-Roussey. Int J Radiat Oncol Biol Phys 13 375.
448. DR Byrd, LK Dunnwald, DA Mankoff, et al. (2001) Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol 8(3), 234-240.
449. A Recht, SB Edge, LJ Solin, et al. (2001) Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19(5), 1539-1569.
450. M Overgaard, MB Jensen, J Overgaard, et al. (1997) Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337 949-954.
451. J Ragaz, SM Jackson, N Ne, et al. (1997) Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer. N Engl J Med 337 956-962.
452. A Recht, SB Edge, LJ Solin, et al. (2001) Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19(5), 1539-1569.
453. L Pierce (2003) The use of radiotherapy after mastectomy: a review of the literature. J Clin Oncol 23(8), 1706-1717.
454. A Taghian, J-H Jeong, E Mamounas, et al. (2004) Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project ran-domized clinical trials. J Clin Oncol 22 4247-4254.
455. I Barreau-Pouhear, MG Le, M Rietjens, et al. (1992) Risk factors for failure of immediate breast reconstruction with prosthesis after total mastectomy for breast cancer. Cancer 70 1145-1151.
456. B Pomahac, A Recht, JW May, et al. (2006) New trends in breast cancer management: is the era of immediate breast reconstruction changing? Ann Surg 244(2), 282-288.
457. M Javaid, F Song, S Leinster, et al. (2006) Radiation effects on the cosmetic outcomes of immediate and delayed autologous breast reconstruction: an argument about timing. J Plast Reconstr Aesthet Surg 59(1), 16-26.
458. SB Motwani, EA Strom, NR Schechter, et al. (2006) The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 66(1), 76-82.
459. DN Danforth Jr, ME Lippman, H McDonald, et al. (1990) Effect of pre-operative chemotherapy on mastectomy for locally advanced breast cancer. Am Surg 56 6-11.
460. Xing Y, Ding M, Ross M, et al. Metaanalysis of sentinel lymph node biopsy following pre operative chemotherapy in patients with operable breast cancer. ASCO Ann Meeting 2004; abstract 561.
461. N Wolmark, J Wang, E Mamounas, et al. (2001) Preoperative chemotherapy in patients with operable breast cancer: nine year results from National Surgical Adjuvant Breast and Bowel Project B-18. Natl Cancer Inst Monogr 96-102.
462. B Fisher, J Dignam, N Wolmark, et al. (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer. Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16 441-452.
463. JP Julien, N Bijker, IS Fentiman, et al. (2000) Radiotherapy in breast conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. Lancet 355 528-533.
464. J Houghton, WD George, J Cuzick, et al. (2003) Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia and New Zealand: randomised controlled trial. Lancet 362 95-102.
465. B Fisher, S Anderson, J Bryant, et al. (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 1233-1241.
466. U Veronesi, E Marubini, L Mariani, et al. (2001) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12 997-1003.
467. K Holli, R Saaristo, J Isalo, et al. (2001) Lumpectomy with or without postoperative radiotherapy for breast cancer with favorable prognostic features: results of a randomized study. Br J Cancer 84 164-169.
468. RM Clark, T Whalen, M Levine, et al. (1996) Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88 1659-1664.
469. F Vicini, K Baglan, L Kestin, et al. (2001) Accelerated treatment of breast cancer. J Clin Oncol 19 1993-2001.
470. F Vicini, V Kini, P Chen, et al. (1999) Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy. J Surg Oncol 70 33-40.
471. R Kuske, K Winter, D Arthur, et al. (2002) A phase I/II trial of brachytherapy alone following lumpectomy for select breast cancer: toxicity analysis of Radiation Therapy Oncology Group 95–17. Int J Radiat Oncol Biol Phys 54 87.
472. Keisch M, Vicini F, Kuske R, et al. Two-year cosmetic outcome with the MammoSite® breast brachytherapy applicator: technical factors associated with optimal results when performing partial breast irradiation. Proceedings of the 45th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Salt Lake City, Utah, October 2003.
473. F Vicini, V Remouchamps, M Wallace, et al. (2003) Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 57 1247-1253.
474. NR Schechter, EA Strom, GH Perkins, et al. (2005) Immediate breast reconstruction can impact postmastectomy irradiation. Am J Clin Oncol 28 485.
475. MA Helvie, JE Bailey, MA Roubidoux, et al. (2002) Mammographic screening of TRAM flap breast reconstructions for detection of nonpalpable recurrent cancer. Radiology 224 211-216.
476. SM Kim and JM Park (2004) Mammographic and ultrasonographic features after autogenous myocutaneous flap reconstruction mammoplasty. J Ultrasound Med 23(2), 275-282.
477. MA LePage, EA Kazerooni, MA Helvie and EG Wilkins (1999) Breast reconstruction with TRAM flaps: normal and abnormal appearance at CT. RadioGraphics 19 1593-1603.
478. RK Devon, MA Rosen, C Mies, et al. (2004) Breast reconstruction with a transverse rectus abdominis myocutaneous flap: spectrum of normal and abnormal MR imaging findings. RadioGraphics 24(5), 1287-1299.
479. AT Monroe, SJ Feigenberg and NP Mendenhall (2003) Angiosarcoma after breast-conserving therapy. Cancer 97(8), 1832-1840.
480. MP Stokkel and HL Peterse (1992) Angiosarcoma of the breast after lumpectomy and radiation therapy for adenocarcinoma. Cancer 69(12), 2965-2968.
481. AI Neugut, E Robinson, WC Lee, et al. (1993) Lung cancer after radiation therapy for breast cancer. Cancer 71(10), 3054-3057.
482. MB Ford, AJ Sigurdson, ES Petrulis, et al. (2003) Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors. Cancer 98 1457-1464.
483. EF Scanlon, O Suh, SM Murthy, et al. (1995) Influence of smoking on the development of lung metastases from breast cancer. Cancer 75(11), 2693-2699.
484. M Clarke, R Collins, S Darby, et al. (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 2087-2106.
485. JD Boice, EB Harvey, M Blettneret, et al. (1992) Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326(12), 781-785.
486. E Obedian, DB Fischer and BG Haffty (2000) Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. J Clin Oncol 18(12), 2406-2412.
487. CA Kelly, XY Wang, JC Chu, et al. (1996) Dose to the contralateral breast: a comparison of four primary breast irradiation techniques. Int J Radiat Oncol Biol Phys 34(3), 727-732.
488. Early Breast Cancer Trialists' Collaborative Group (2000) Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 355 1757-1770.
489. Early Breast Cancer Trialists' Collaborative Group (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 years survival: an overview of randomized trials. Lancet 366 2087-2106.
490. EER Harris, C Correa, WT Hwang, et al. (2006) Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol 24(25), 4100-4106.
491. AT Stavros, D Thickman, CL Rapp, et al. (1995) Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 196 123-134.
492. SD Davis, DF Yankelevitz and CI Henschke (1992) Radiation effects on the lung: clinical features, pathology, and imaging findings. AJR Am J Roentgenol 159 1157-1164.
493. JI Jung, HH Kim, SH Park, et al. (2004) Thoracic manifestations of breast cancer and its therapy. RadioGraphics 24 1269-1285.
494. N Morakkabati, CC Leutner, A Schmiedel, et al. (2003) Breast MR Imaging during or soon after radiation therapy. Radiology 229 893-901.
495. HR Withers (1967) The dose-survival relationship for irradiation of epithelial cells of mouse skin. Br J Radiol 40 187.
496. L Liberman, DD Dershaw, RJ Kaufman, et al. (1992) Angiosarcoma of the breast. Radiology 183 649. (Retrospective review of 29 cases of primary angiosarcoma of the breast.)
497. LK Marchant, SG Orel, LA Perez-Jaffe, et al. (1997) Bilateral angiosarcoma of the breast on MR imaging. AJR Am J Roentgenol 169 1009-1010. (Case report of bilateral primary angiosarcoma appearance on breast MRI.)